Trending...
- Arizona Christian Homeschools Launches Statewide Directory
- Ricci's Painting & Contracting Expands Home Transformation Services
- Senco Home Services Expands Residential Construction Services
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina NextSeq™ 1000 and NextSeq™ 2000 sequencing systems and the GeoMx® Digital Spatial Profiler. The spatial analysis of whole transcriptomes combined with proteome analytes can now be simplified using this integrated, push-button run planning tool.
The new integrated workflow allows GeoMx users to plan their NextSeq 1000/2000 sequencing runs using software on the GeoMx instrument and is coupled to automated downstream data processing using the DRAGEN™ Bio-IT platform, Illumina's industry-leading platform for secondary data analysis. Upon completion of sequence processing, the spatially-resolved digital counts of RNA or protein are ported directly to the GeoMx system, allowing researchers to interact, visualize and analyze their multiomic data.
"As a company, we strive to create end-to-end spatial solutions that are simpler, faster, and more relevant to today's life science challenges," said John Gerace, Chief Commercial Officer, NanoString. "Working together with Illumina, we are ensuring the increasing volume of data is analyzed promptly and that the workflow between our companies' instruments is streamlined to improve customer experiences."
"Illumina is committed to enabling compatible and streamlined workflows with our partner solutions to ensure our customers can implement the workflows that best answer their research questions," said Joel Fellis, VP of Sequencing Platforms Product Management, Illumina. "NanoString's GeoMx Digital Spatial Profiler is enabling a new frontier in discovery research using whole transcriptome analysis and protein detection with spatial context."
More on Washingtoner
The release of the new integrated workflow complements a suite of previously released spatial genomics workflows from the NanoString and Illumina partnership. This includes the GeoMx NGS Pipeline with DRAGEN as a third-party application accessible on the BaseSpace™ Sequence Hub that enables easy coupling of the pipeline processing downstream from any Illumina sequencing platform. The team also co-developed an integrated local workflow with the release of the NanoString GeoMx NGS Pipeline on DRAGEN for NextSeq 1000/2000 platforms to enable customers whose instruments may not be networked. The full suite of streamlined NGS informatics workflows enables GeoMx customers to choose which one best meets their needs.
About NanoString Technologies, Inc
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString's GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in more than 100 peer-reviewed publications. The CosMx™ Spatial Molecular Imager, with commercial availability expected in 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections. For more information, visit www.nanostring.com.
More on Washingtoner
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our products and the anticipated launch of new products and technology. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include market acceptance of our products; delays or denials of regulatory approvals or clearances for products or applications; the extent and duration of the impact of the COVID-19 pandemic and adverse conditions in the general domestic and global economic markets; the effects of ongoing litigation; the impact of competition; the impact of expanded sales, marketing, product development and clinical activities on operating expenses; delays or other unforeseen problems with respect to manufacturing and product development; as well as the other risks set forth in our filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. NanoString Technologies disclaims any obligation to update these forward-looking statements.
NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
Contacts
Doug Farrell, NanoString
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768
The new integrated workflow allows GeoMx users to plan their NextSeq 1000/2000 sequencing runs using software on the GeoMx instrument and is coupled to automated downstream data processing using the DRAGEN™ Bio-IT platform, Illumina's industry-leading platform for secondary data analysis. Upon completion of sequence processing, the spatially-resolved digital counts of RNA or protein are ported directly to the GeoMx system, allowing researchers to interact, visualize and analyze their multiomic data.
"As a company, we strive to create end-to-end spatial solutions that are simpler, faster, and more relevant to today's life science challenges," said John Gerace, Chief Commercial Officer, NanoString. "Working together with Illumina, we are ensuring the increasing volume of data is analyzed promptly and that the workflow between our companies' instruments is streamlined to improve customer experiences."
"Illumina is committed to enabling compatible and streamlined workflows with our partner solutions to ensure our customers can implement the workflows that best answer their research questions," said Joel Fellis, VP of Sequencing Platforms Product Management, Illumina. "NanoString's GeoMx Digital Spatial Profiler is enabling a new frontier in discovery research using whole transcriptome analysis and protein detection with spatial context."
More on Washingtoner
- Why More Phoenix Families Are Turning to Private Autopsy Services for Answers
- City of Tacoma Observes Independence Day
- Make America French Again Launches National Campaign
- AI Researcher Releases Punk Album "You Can't Kill The Signal" In Response To Mythos and Fable Ban
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
The release of the new integrated workflow complements a suite of previously released spatial genomics workflows from the NanoString and Illumina partnership. This includes the GeoMx NGS Pipeline with DRAGEN as a third-party application accessible on the BaseSpace™ Sequence Hub that enables easy coupling of the pipeline processing downstream from any Illumina sequencing platform. The team also co-developed an integrated local workflow with the release of the NanoString GeoMx NGS Pipeline on DRAGEN for NextSeq 1000/2000 platforms to enable customers whose instruments may not be networked. The full suite of streamlined NGS informatics workflows enables GeoMx customers to choose which one best meets their needs.
About NanoString Technologies, Inc
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString's GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in more than 100 peer-reviewed publications. The CosMx™ Spatial Molecular Imager, with commercial availability expected in 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections. For more information, visit www.nanostring.com.
More on Washingtoner
- Spokane: Domestic Disturbance Call Results in Serious Injury to Dog
- Spokane: Camp Sekani Update 7/1/26
- Spokane: Clocktower Chimes to Ring Once Again
- Tacoma: Regional Coalition to Unveil Draft Commencement Bay Restoration and Resilience Master Plan at Community Open House on July 15
- A Novelist and an Essayist Walk Into a Podcast and Reach the Same Conclusion
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our products and the anticipated launch of new products and technology. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include market acceptance of our products; delays or denials of regulatory approvals or clearances for products or applications; the extent and duration of the impact of the COVID-19 pandemic and adverse conditions in the general domestic and global economic markets; the effects of ongoing litigation; the impact of competition; the impact of expanded sales, marketing, product development and clinical activities on operating expenses; delays or other unforeseen problems with respect to manufacturing and product development; as well as the other risks set forth in our filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. NanoString Technologies disclaims any obligation to update these forward-looking statements.
NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
Contacts
Doug Farrell, NanoString
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768
0 Comments
Latest on Washingtoner
- Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
- Tacoma: System Development Charges for Wastewater and Stormwater Utilities to Take Effect on July 1
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street
- Data Tiles Introduces the Decision-Driven Enterprise to North America
- Disruptor Creations Pioneers New MicroAdventure Series with TravelSpike
- Spokane City Fire Marshal Issues Outdoor Recreational Fire Restriction
- eCopier Solutions Surpasses 3,000 Five-Star Google Reviews and Maintains Perfect Five-Star Rating
- Creative Investment Research Welcomes Supreme Court Decision Protecting Federal Reserve Independence While Calling for Continued Accountability
- Ascent Solar Technologies (N A S D A Q: ASTI): Positioned at the Intersection of the New Space Economy, Defense Innovation and Next-Generation Energy
- Triple-Digit Growth, Stock Market Upgrade plus a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Morrisville & Cary Education Centers Honored with National Award
- AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
- Henri-Lloyd Launches Sail Free to Break Down Barriers to Sailing
- Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Jacksonville JTB/Deerwood Park
- Destination Niagara Launches Game Changing Digital Magazine Redefining How Visitors Experience Niagara Falls
- San Diego's newest marketing firm is boring on purpose — it's working
- Arizona Christian Homeschools Launches Statewide Directory